As the primary ligand of CCR3 (C‐C Motif Chemokine Receptor 3), Eotaxin‐1 has been identified as involved in the tumor‐associated inflammation that facilitates the development and progression of CCR3‐positive RCC.2 Here, CCR3 is linked to neoplasm.